CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions		3 Months Ended				6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021		Jun. 30, 2022	Jun. 30, 2021
Revenues
Total Revenues		$ 1,636		$ 1,602		$ 3,183	$ 3,088
Costs and Expenses, Net
Company restaurant expenses		415		417		817	809
General and Administrative Expense		254		230		507	436
Franchise and property expenses		29		27		61	50
Franchise advertising and other services expense		396		372		757	715
Refranchising (gain) loss		(8)		(7)		(12)	(22)
Other (income) expense		(4)		(4)		(10)	(10)
Total costs and expenses, net		1,082		1,035		2,120	1,978
Operating Profit		554		567		1,063	1,110
Investment (income) expense, net	[1]	15		(1)		8	(1)
Other pension (income) expense		1		2		1	5
Interest expense, net		148	[2]	159	[2]	266	290	[2]
Income Before Income Taxes		390		407		788	816
Income tax provision		166		16		165	99
Net Income		$ 224		$ 391		$ 623	$ 717
Basic Earnings Per Common Share		$ 0.78		$ 1.31		$ 2.16	$ 2.39
Diluted Earnings Per Common Share		0.77		1.29		2.13	2.35
Dividends Declared Per Common Share		$ 0.57		$ 0.50		$ 1.14	$ 1.00
Company Sales
Revenues
Revenues		$ 499		$ 520		$ 969	$ 996
Franchise and property revenues
Revenues
Revenues		737		706		1,451	1,364
Franchise contributions for advertising and other services
Revenues
Revenues		$ 400		$ 376		$ 763	$ 728

[1] Includes changes in the value of our investment in Devyani International Limited (see Note 12).

[2] Includes a $23 million call premium and $5 million of unamortized debt issuance costs written off related to the redemption of the 2025 Notes (see Note 10) during the quarter ended June 30, 2022. Includes a $28 million call premium and $6 million of unamortized debt issuance costs written off related to the redemption of the $1,050 million aggregate principal amount of 5.25% Subsidiary Senior Unsecured Notes due in 2026 during the quarter ended June 30, 2021. Includes fees expensed and unamortized debt issuance costs written off totaling $12 million related to the refinancing of the Credit Agreement (as described within our 2021 Form 10-K) during the quarter ended March 31, 2021.